Nexalin Technology Inc Warrants (15/09/2025) NXLIW 深 沪
已收盘 09-19 16:00:00 美东时间
0.0138
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0138
- 总市值 0
- 52周最高 0.78
- 市盈率 静 --
- 换手率 NaN.00%
- 52周最低 0.008
- 委 比 0.00%
- 总股本 --
- 历史最高 0.78
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.0051
- 每 手 1
- 风险率 0.10%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs
Nexalin Technology, Inc. announced the appointment of Dr. Robert Rothstein to its Scientific Advisory Board (SAB). With over four decades of experience in emergency medicine and mental health, Dr. Rothstein will support Nexalin’s FDA submissions and clinical trials for Alzheimer’s disease and Traumatic Brain Injury (TBI). His addition strengthens Nexalin’s focus on advancing Deep Intracranial Frequency Stimulation (DIFS™) technology to address ne...
2025-10-13 12:30
Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements
Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW)) announced that the Company received notice from The Nasdaq Stock Market ("Nasdaq") on October 31, 2024, notifying the Company that it has
2024-11-01 22:39
Reported Earlier, Nexalin Technology Raises $5.25M Via Public Offering Of 3M Shares At $1.75/Share
Nexalin Technology, Inc. (NASDAQ:NXL, NXLIW)))) (the "Company" or "Nexalin") today announced the pricing of a public offering of 3,000,000 shares of common stock at public offering price
2024-06-28 15:23
Nexalin Technology Regains Compliance With Nasdaq Continued Listing Requirements
Nexalin Technology, Inc. (the "Company" or "Nexalin") (NASDAQ:NXL, NXLIW))) announced that the Company received notice from The Nasdaq Stock Market ("Nasdaq") on April 23, 2024, notifying the Company that it has regained
2024-04-25 22:49
